Correlation Engine 2.0
Clear Search sequence regions

  • behavior (1)
  • clients (1)
  • contract (3)
  • fee (1)
  • help (1)
  • research (4)
  • Sizes of these terms reflect their relevance to your search.

    Outsourcing has become an integral part of how research and early development (R&D) is executed in biotech companies and large pharmaceutical organizations. Drug discovery organizations can choose from several operational models when partnering with a service provider, ranging from short-term, fee-for-service (FFS)-based arrangements to more strategic full-time-equivalent (FTE)-based collaborations and even risk-sharing relationships. Clients should consider a number of criteria when deciding which contract research organization (CRO) is best positioned to help meet their goals. Besides cost, other factors such as intellectual property protection, problem solving skills, value-creation ability, communication, data integrity, safety and personnel policies, ease of communication, geography, duration of engagement, scalability of capacity, and contractual details deserve proper consideration. In the end, the success of a drug discovery partnership will depend in large part on the people who execute the science.


    Bart L DeCorte. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization. Journal of medicinal chemistry. 2020 Oct 22;63(20):11362-11367

    Expand section icon Mesh Tags

    PMID: 32479727

    View Full Text